ASTH
Astrana Health Inc
37.60$
+4.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.0% | +31.4% | +2.1% | +2.6% | +5.4% | -1.7% | +8.3% | +55.1% | -0.8% | +6.3% | -3.3% | |
| – | -3.1% | +16.4% | +5.9% | +4.9% | +7.0% | -4.0% | +18.9% | +21.2% | -2.3% | +16.3% | -8.5% | |
| – | +7.3% | +14.0% | -2.8% | +7.0% | -17.1% | -10.4% | +31.4% | +36.1% | -7.1% | +11.4% | -16.2% | |
| – | +7.0% | +13.8% | -2.8% | +6.9% | -17.0% | -10.3% | +31.1% | +35.5% | -7.3% | +11.4% | -16.2% | |
| – | -20.3% | +24.7% | +22.3% | +0.4% | +43.6% | +1.2% | +11.1% | +8.7% | +2.7% | +22.7% | -1.5% | |
| – | +1.2% | +47.1% | -0.2% | +0.0% | +2.3% | -0.7% | +0.1% | +107.1% | +0.1% | +1.3% | +1.4% | |
| – | -3.5% | +67.1% | -2.9% | -6.1% | +8.3% | -5.3% | -5.5% | +169.6% | -4.9% | -5.1% | -5.4% | |
| – | +14.2% | +48.1% | 0.0% | +0.6% | +8.0% | -3.2% | +11.2% | +86.0% | -1.3% | +7.3% | -5.5% | |
| – | +7.7% | +62.5% | -12.8% | +1.0% | +16.8% | -1.2% | +27.3% | +37.0% | -2.3% | +21.1% | +0.3% | |
| – | +245.0% | +6.6% | -14.8% | -7.5% | -26.5% | +17.5% | -0.7% | +208.9% | +1.1% | -0.5% | +13.3% | |
| – | -1.5% | +835.2% | -55.0% | -3.4% | -58.9% | -1.7% | -3.9% | +308.3% | -23.3% | +21.2% | +352.5% | |
| – | +25.6% | +42.3% | +15.4% | -0.4% | +0.5% | -5.0% | -0.7% | +149.8% | -1.1% | -1.1% | -9.9% | |
| – | +3.5% | +6.4% | +3.9% | +3.8% | +1.2% | +4.6% | +2.7% | +1.3% | +0.5% | +2.7% | +3.7% | |
| – | +5.4% | +6.1% | +7.4% | +5.8% | -2.4% | +2.3% | +3.2% | +0.1% | +1.9% | +4.6% | +6.1% | |
| – | +1.3% | +0.7% | +0.3% | +0.5% | -0.6% | +1.9% | +1.3% | +0.0% | +0.1% | -1.0% | +1.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.